NCT07132645View on ClinicalTrials.gov

An Investigational Scan ([68Ga] Ga-FAPI-04 PET/CT) for the Imaging of Patients With High-Grade Neuroendocrine Cancer

EARLY_PHASE1RecruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

September 16, 2025

Primary Completion Date

September 1, 2027

Study Completion Date

September 1, 2027

Conditions
Neuroendocrine Tumor
Interventions
PROCEDURE

Computed Tomography

Undergo CT scan

DRUG

Gallium Ga 68-DOTA-FAPI-04

Given IV

PROCEDURE

Positron Emission Tomography

Undergo PET scan

Trial Locations (1)

48109

RECRUITING

University of Michigan Comprehensive Cancer Center, Ann Arbor

All Listed Sponsors
collaborator

Neuroendocrine Research Foundation

UNKNOWN

lead

University of Michigan Rogel Cancer Center

OTHER